Show simple item record

R&D Costs and Returns to New Drug Development: A Review of the Evidence

dc.contributor.author DiMasi, Joseph A
dc.contributor.author Grabowski, Henry G
dc.date.accessioned 2013-05-13T17:32:46Z
dc.date.issued 2012-09-18
dc.identifier.isbn 9780199968749
dc.identifier.uri http://hdl.handle.net/10161/7342
dc.description.abstract © 2012 by Oxford University Press. All rights reserved.This article reviews the extensive literature on R&D costs and returns. The first section focuses on R&D costs and the various factors that have affected the trends in real R&D costs over time. The second section considers economic studies on the distribution of returns in pharmaceuticals for different cohorts of new drug introductions. It also reviews the use of these studies to analyze the impact of policy actions on R&D costs and returns. The final section concludes and discusses open questions for further research.
dc.relation.ispartof The Oxford Handbook of the Economics of the Biopharmaceutical Industry
dc.relation.isversionof 10.1093/oxfordhb/9780199742998.013.0002
dc.title R&D Costs and Returns to New Drug Development: A Review of the Evidence
dc.type Book section
pubs.organisational-group Duke
pubs.organisational-group Economics
pubs.organisational-group Trinity College of Arts & Sciences
pubs.publication-status Published


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record